CONCLUSION

Metastatic renal EAML is a rare disease. With mTOR inhibitor treatment showing rather positive effect in an adequate therapeutic dose. Vigilance and awareness of drug interactions is of an extreme importance. These interactions can be overcome with proper drug or dose changes. Figure 1: Pharmacokinetic curve of temsirolimus and sirolimus before and after dose adjustment.